Noxon Overview
Noxon develops a novel drug for oral treatment of fibrotic lung diseases. The developed drug, 3-cabamoyl-proxyl, is a stable organic radical belonging to the nitroxides group. Its product, 3-CP, which has a unique antioxidant property, has been shown to reduce airway inflammation, airway hyper-responsiveness, and other inflammatory mediators of the lung tissues, as seen in animal models of allergic asthma.
Cumulative Funding Raised Over Time ($)
Latest News
No news articles.
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Pre-Seed |
| Rounds | 1 |
| Investors | 1 |
Team Members
1
Employees: 1-10
Web & Social Links
| Website | ngt-healthcare2.com/noxon/ |
Locations
Wadi el-Haj St 13, Nazareth, Israel
Photos & Videos
No files yet
Noxon Business
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentTarget Customer
Healthcare & Life SciencesLife SciencesPharmaceuticalsCore Technology
BiologicalsTags (4)
pharmaceuticalsdrug-discoveryhealthcareoral-drugsNoxon Financials
Cumulative Funding Raised Over Time ($)
Private Equity Funding
Noxon Lifecycle
Cumulative Funding Raised Over Time
All Events
Noxon News
0 articlesNo news articles.
Noxon Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 6 |
| Team members | 1 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 7 classification IDs that could be used for matching.
Noxon Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 87/100 |
| Missing | video or image, news, markets, external profiles, not claimed |
| BI Verification | Yanina Wainscheinker |
| Registrar ID | 516731973 |
| Creator | Ortal Wein |
| Creator email | ortalw@sncentral.org |
| Last updater | Ortal Wein |
| Updater email | ortalw@sncentral.org |
| Last update | 2023-03-21T00:00:00.000Z |
| Created | 2023-03-21T00:00:00.000Z |